Biocytogen Pharmaceuticals-B(02315) recommends appointing Liu Hongkang as a non-executive director
Bosaidoo (02315) announced that, following the nomination by the Nomination Committee and the approval by the Board of Directors, it was recommended at the Board meeting held on January 27, 2026 to appoint Mr. Liu Hongkang as a non-executive director.
Biocytogen Pharmaceuticals-B (02315) announced that, following the nomination by the Nomination Committee and approval by the Board of Directors, it was recommended at the Board meeting held on January 27, 2026 to appoint Mr. Liu Hongkang as a non-executive director.
Related Articles
Bidding for Warner Bros. (WBD.US) enters a critical period, while Paramount Skydance (PSKY.US) speeds up the antitrust review process.
US Stock Market Move | Multiple departments issued letters to support the new consumption and financial consumption driving LexinFintech Holdings Ltd. Sponsored ADR Class A (LX.US) to rise by 6.04%.
Industry's First Rider Family Hospitalization Protection Implemented Meituan Upgrades Major Illness Care Plan Covering Over One Million Rider Families
Bidding for Warner Bros. (WBD.US) enters a critical period, while Paramount Skydance (PSKY.US) speeds up the antitrust review process.
US Stock Market Move | Multiple departments issued letters to support the new consumption and financial consumption driving LexinFintech Holdings Ltd. Sponsored ADR Class A (LX.US) to rise by 6.04%.
Industry's First Rider Family Hospitalization Protection Implemented Meituan Upgrades Major Illness Care Plan Covering Over One Million Rider Families
